{"id":"https://openalex.org/W4414554558","doi":"https://doi.org/10.1186/s12981-025-00788-8","title":"High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidence","display_name":"High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidence","publication_year":2025,"publication_date":"2025-09-26","ids":{"openalex":"https://openalex.org/W4414554558","doi":"https://doi.org/10.1186/s12981-025-00788-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/41013566","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12465354"},"language":"en","primary_location":{"id":"doi:10.1186/s12981-025-00788-8","doi":"https://doi.org/10.1186/s12981-025-00788-8","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12981-025-00788-8","pdf_url":"https://aidsrestherapy.biomedcentral.com/counter/pdf/10.1186/s12981-025-00788-8","source":{"id":"https://openalex.org/S22960011","display_name":"AIDS Research and Therapy","issn_l":"1742-6405","issn":["1742-6405"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aidsrestherapy.biomedcentral.com/counter/pdf/10.1186/s12981-025-00788-8","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073676223","display_name":"Amalia Carolina Gir\u00f3n-Callejas","orcid":"https://orcid.org/0000-0001-8242-0436","observed_orcids":["https://orcid.org/0000-0001-8242-0436"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Amalia Gir\u00f3n-Callejas","raw_affiliation_strings":["School of Public Health, Imperial College London, 90 Wood Lane, W12 0BZ, London, UK. amalia.giron-callejas21@alumni.imperial.ac.uk","School of Public Health, Imperial College London, 90 Wood Lane, W12 0BZ, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, Imperial College London, 90 Wood Lane, W12 0BZ, London, UK. amalia.giron-callejas21@alumni.imperial.ac.uk","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"School of Public Health, Imperial College London, 90 Wood Lane, W12 0BZ, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047086198","display_name":"Rolando Lorenzana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154024","display_name":"ICAP Global Health","ror":"https://ror.org/01f0vkh84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4387154024","https://openalex.org/I78577930"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rolando Lorenzana","raw_affiliation_strings":["ICAP, Columbia University, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICAP, Columbia University, New York, USA","institution_ids":["https://openalex.org/I4387154024","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024486371","display_name":"Michael Pickles","orcid":"https://orcid.org/0000-0002-6754-3945","observed_orcids":["https://orcid.org/0000-0002-6754-3945"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Pickles","raw_affiliation_strings":["HIV Prevention Trials Network Modelling Centre, Imperial College London, London, UK","Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV Prevention Trials Network Modelling Centre, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058207584","display_name":"Seth Chekata Inzaule","orcid":"https://orcid.org/0000-0002-0155-7391","observed_orcids":["https://orcid.org/0000-0002-0155-7391"]},"institutions":[{"id":"https://openalex.org/I4210124406","display_name":"Amsterdam Institute for Global Health and Development","ror":"https://ror.org/037n2rm85","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210124406"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Seth Inzaule","raw_affiliation_strings":["Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210124406","https://openalex.org/I4210151833","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052083685","display_name":"Michael R. Jordan","orcid":"https://orcid.org/0000-0002-2177-0405","observed_orcids":["https://orcid.org/0000-0002-2177-0405"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT","US"],"is_corresponding":false,"raw_author_name":"Michael R. Jordan","raw_affiliation_strings":["Center for Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, 1349-008, Portugal","Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, USA","Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, 1349-008, Portugal","institution_ids":["https://openalex.org/I83558840"]},{"raw_affiliation_string":"Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, USA","institution_ids":["https://openalex.org/I121934306"]},{"raw_affiliation_string":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034863807","display_name":"Sheilee L. D\u00edaz","orcid":"https://orcid.org/0000-0002-7525-6866","observed_orcids":["https://orcid.org/0000-0002-7525-6866"]},"institutions":[{"id":"https://openalex.org/I91044043","display_name":"Universidad del Valle de Guatemala","ror":"https://ror.org/03nyjqm54","country_code":"GT","type":"education","lineage":["https://openalex.org/I91044043"]}],"countries":["GT"],"is_corresponding":false,"raw_author_name":"Sheilee Diaz","raw_affiliation_strings":["Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala, Guatemala"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala, Guatemala","institution_ids":["https://openalex.org/I91044043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089716502","display_name":"Charlotte Vrinten","orcid":"https://orcid.org/0000-0002-6187-0638","observed_orcids":["https://orcid.org/0000-0002-6187-0638"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Vrinten","raw_affiliation_strings":["School of Public Health, Imperial College London, 90 Wood Lane, W12 0BZ, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, Imperial College London, 90 Wood Lane, W12 0BZ, London, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5073676223"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":1.4868,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.79893022,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"22","issue":"1","first_page":"91","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.06449999660253525,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-viral-suppression","display_name":"HIV viral suppression","score":0.8289999961853027},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.9350000023841858},{"id":"https://openalex.org/keywords/first-line-antiretroviral-therapy","display_name":"first-line antiretroviral therapy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/who-treatment-guidelines","display_name":"WHO treatment guidelines","score":0.7429999709129333},{"id":"https://openalex.org/keywords/low-and-middle-income-countries","display_name":"low- and middle-income countries","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hiv-treatment-outcomes","display_name":"HIV treatment outcomes","score":0.4959999918937683},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.6819999814033508},{"id":"https://openalex.org/keywords/intention-to-treat-analysis","display_name":"intention-to-treat analysis","score":0.6779999732971191},{"id":"https://openalex.org/keywords/unaids-95-95-95-targets","display_name":"UNAIDS 95-95-95 targets","score":0.9049999713897705},{"id":"https://openalex.org/keywords/adults-with-hiv","display_name":"adults living with HIV","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9563999772071838},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.7660999894142151},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6211000084877014},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.45730000734329224},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39959999918937683},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3598000109195709},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3492000102996826},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.3359000086784363},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33329999446868896},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3294000029563904},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C2909254382","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"ANTIRETROVIRAL AGENTS","level":5,"score":0.2775999903678894},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.25119999051094055}],"mesh":[{"descriptor_ui":"D000099226","descriptor_name":"Dolutegravir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003906","descriptor_name":"Developing Countries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014944","descriptor_name":"World Health Organization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1186/s12981-025-00788-8","doi":"https://doi.org/10.1186/s12981-025-00788-8","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12981-025-00788-8","pdf_url":"https://aidsrestherapy.biomedcentral.com/counter/pdf/10.1186/s12981-025-00788-8","source":{"id":"https://openalex.org/S22960011","display_name":"AIDS Research and Therapy","issn_l":"1742-6405","issn":["1742-6405"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11273675","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12465354","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41013566","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41013566","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS research and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12465354","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12465354/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Res Ther","raw_type":"Text"},{"id":"pmh:oai:run.unl.pt:10362/200435","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/200435","pdf_url":"https://run.unl.pt/bitstreams/8759fded-f90d-46dd-9917-fcababe4a72b/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:doaj.org/article:afb9cbac16964d94a5cb8718337dd9d0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/afb9cbac16964d94a5cb8718337dd9d0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS Research and Therapy, Vol 22, Iss 1, Pp 1-16 (2025)","raw_type":"article"},{"id":"pmh:oai:spiral.imperial.ac.uk:10044/1/123636","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10044/1/123636","pdf_url":null,"source":{"id":"https://openalex.org/S4306401396","display_name":"Spiral (Imperial College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I47508984","host_organization_name":"Imperial College London","host_organization_lineage":["https://openalex.org/I47508984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/s12981-025-00788-8","doi":"https://doi.org/10.1186/s12981-025-00788-8","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12981-025-00788-8","pdf_url":"https://aidsrestherapy.biomedcentral.com/counter/pdf/10.1186/s12981-025-00788-8","source":{"id":"https://openalex.org/S22960011","display_name":"AIDS Research and Therapy","issn_l":"1742-6405","issn":["1742-6405"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[{"id":"https://openalex.org/G6492113386","display_name":"MRC Centre for Global Infectious Disease Analysis (MRC GIDA)","funder_award_id":"MR/X020258/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G9000226676","display_name":null,"funder_award_id":"NIH UM1 AI068617","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000897886","display_name":"SDMC: HIV Prevention Trials Network","funder_award_id":"UM1AI068617","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320320283","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414554558.pdf","grobid_xml":"https://content.openalex.org/works/W4414554558.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W2055868383","https://openalex.org/W2215476268","https://openalex.org/W2417616718","https://openalex.org/W2508295414","https://openalex.org/W2510140996","https://openalex.org/W2582743722","https://openalex.org/W2800677865","https://openalex.org/W2946614548","https://openalex.org/W2975424845","https://openalex.org/W3015269463","https://openalex.org/W3082610478","https://openalex.org/W3093018885","https://openalex.org/W3148962211","https://openalex.org/W3157530046","https://openalex.org/W3173951581","https://openalex.org/W3213364294","https://openalex.org/W4206273165","https://openalex.org/W4210988915","https://openalex.org/W4240484632","https://openalex.org/W4241964765","https://openalex.org/W4282977912","https://openalex.org/W4288032966","https://openalex.org/W4289527614","https://openalex.org/W4292264728","https://openalex.org/W4293577973","https://openalex.org/W4313502514","https://openalex.org/W4362474263","https://openalex.org/W4377983707","https://openalex.org/W4379793405","https://openalex.org/W4385076708","https://openalex.org/W4385423923","https://openalex.org/W4390903428","https://openalex.org/W4391657616","https://openalex.org/W4396581888","https://openalex.org/W4396658690","https://openalex.org/W4396676811","https://openalex.org/W4396916605","https://openalex.org/W4399402064","https://openalex.org/W4401682203","https://openalex.org/W4408879355","https://openalex.org/W4409814189"],"related_works":["https://openalex.org/W7131340570","https://openalex.org/W7084160438","https://openalex.org/W4401568802","https://openalex.org/W7138937507","https://openalex.org/W7215074514","https://openalex.org/W7203441890","https://openalex.org/W4377983707","https://openalex.org/W7168288491","https://openalex.org/W3173951581","https://openalex.org/W4400036125"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"systematic":[2,27],"review":[3],"and":[4,21,33,39,49,99,139,154,255],"meta-analysis":[5],"assessed":[6],"viral":[7,53,119,171,201,236],"suppression":[8,54,120,172,202,237,253],"among":[9,55],"adults":[10,56,90],"receiving":[11,57,230],"WHO-recommended":[12,58,231],"first-line":[13,59,232],"dolutegravir-based":[14,60,95,233,260],"ART":[15,61,180,215,234],"in":[16,19,62,175,228,262],"programmatic":[17],"settings":[18],"low-":[20],"middle-income":[22],"countries":[23,114],"(LMICs).":[24],"METHODS:":[25],"A":[26],"search":[28],"of":[29,239,259],"Ovid":[30],"MEDLINE,":[31],"Embase,":[32],"major":[34],"HIV":[35,264],"conferences":[36],"(IAS,":[37],"AIDS,":[38],"CROI)":[40],"from":[41,112],"January":[42],"2019":[43],"to":[44,94,110,243],"September":[45],"2024":[46],"identified":[47],"cohort":[48],"cross-sectional":[50],"studies":[51,106],"reporting":[52],"LMICs.":[63],"Studies":[64],"with":[65,162,187,210,249],"follow-ups":[66],"\u2264":[67],"4":[68],"months":[69,192],"or":[70],"using":[71,80],"non-WHO-recommended":[72],"regimens":[73,261],"were":[74,78,102,115],"excluded.":[75],"Pooled":[76],"estimates":[77],"calculated":[79],"random-effects":[81],"meta-analysis.":[82],"Sensitivity":[83,148],"analyses":[84,88],"excluded":[85],"outliers.":[86],"Subgroup":[87],"distinguished":[89],"initiating":[91,179],"versus":[92],"transitioning":[93,177,220],"ART.":[96],"Both":[97],"on-treatment":[98],"intention-to-treat":[100,199],"outcomes":[101],"assessed.":[103],"RESULTS:":[104],"Twenty-two":[105],"(n":[107],"=":[108,134,143,195,208,223],"47":[109],"50,742)":[111],"13":[113],"included.":[116],"On-treatment":[117],"pooled":[118,198],"was":[121,173,204],"95%":[122,241,252],"(95%":[123],"CI:":[124],"91-97%,":[125],"I\u00b2=":[126],"96%)":[127],"at":[128,136,145,165,190],"six":[129],"months,":[130,138,170],"96%":[131],"(94-98%,":[132],"I\u00b2":[133,142,207],"97%)":[135],"12":[137,166,191],"98%":[140],"(96-99%,":[141],"94%)":[144],"24":[146],"months.":[147,167],"analysis":[149],"removing":[150],"outliers":[151],"decreased":[152],"heterogeneity":[153],"slightly":[155],"lowered":[156],"the":[157,250,257],"6\u2011month":[158],"estimate":[159],"(to":[160],"94%),":[161],"negligible":[163],"change":[164],"At":[168],"6":[169],"higher":[174],"those":[176],"than":[178],"(98%":[181],"vs.":[182,219],"94%,":[183],"p":[184,194,222],"<":[185],"0.01),":[186],"similar":[188],"rates":[189,238],"(97%,":[193],"0.67).":[196],"The":[197],"12-month":[200],"rate":[203],"89%":[205],"(82-93%,":[206],"95%),":[209],"no":[211],"significant":[212],"difference":[213],"by":[214],"status":[216],"(initiating":[217],"86%":[218],"91%,":[221],"0.44).":[224],"CONCLUSION:":[225],"Adults":[226],"retained":[227],"care":[229],"achieved":[235],"\u2265":[240],"up":[242],"two":[244],"years.":[245],"These":[246],"findings":[247],"align":[248],"UNAIDS":[251],"target":[254],"reinforce":[256],"role":[258],"ending":[263],"as":[265],"a":[266],"public":[267],"health":[268],"threat.":[269],"TRIAL":[270],"REGISTRATION:":[271],"CRD42024557769.":[272]},"counts_by_year":[{"year":2026,"cited_by_count":12}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-10-10T00:00:00"}